April 11, 2013Placement Agent Agreement • May 15th, 2013 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • New York
COMMON STOCK PURCHASE WARRANT ARCA BIOPHARMA, INC.Common Stock Purchase Warrant • May 15th, 2013 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to the close of business on the five (5) year anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from ARCA biopharma, Inc., a Delaware corporation (the “Company”), up to [*] shares (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ARCA biopharma, Inc., Computershare Inc. and Computershare Trust Company, N.A. as Warrant Agent Warrant Agency Agreement Dated as of , 2013Warrant Agency Agreement • May 15th, 2013 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • New York
WARRANT AGENCY AGREEMENT, dated as of , 2013 (“Agreement”), between ARCA biopharma, Inc., a Delaware corporation (the “Company”), Computershare Inc., a Delaware corporation (“Computershare”), and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered, limited purpose trust company (together with Computershare, the “Warrant Agent”).
